Nrf2-IN-1

Nrf2-IN-1 is an inhibitor of nuclear factor-erythroid 2-related factor 2 (Nrf2) . Nrf2-IN-1 is developed for the research of acute myeloid leukemia (AML) In Vitro Nrf2-IN-1 (Compound 4f) (10 μM) inhibits Nrf2 activation. ? Nrf2-IN-1(1-20 μM; 48 hours) inhibits growth of the three AML cell. ? Nrf2-IN-1 (5-10 μM; 48 hours) induces apoptosis of three AML cells in vitro. ? Nrf2-IN-1 induces apoptotic signaling involving Bcl-2 and Bax. MCE has not independently confirmed the accuracy of these methods. They are for reference only. Cell Viability AssayCell Line: THP-1 cells, HL-60 cells, U937 cells Concentration: 1 μM, 5 μM, 10 μM, 20 μM Incubation Time: 48 hours Result: Inhibited growth of the three AML cell types at 5 μM, 10 μM or 20 μM for 48 hours. Apoptosis AnalysisCell Line: THP-1 cells, HL-60 cells, U937 cells Concentration: 5 μM, 10 μM Incubation Time: 48 hours Result: Induced apoptosis in AML cells in vitro. Western Blot AnalysisCell Line: THP-1 cells, HL-60 cells, U937 cells Concentration: 5 μM, 10 μM Incubation Time: 48 hours Result: Triggered caspase-dependent apoptotic signaling in AML cells. In Vivo Nrf2-IN-1 inhibits tumor growth via apoptosis in chicken eggs . MCE has not independently confirmed the accuracy of these methods. They are for reference only. Form:Solid IC50& Target:Nrf2

No numbering system information yet

No physical and chemical property information yet

No safety information yet

No production method and use information yet

No upstream information yet

No downstream information yet

No related product information yet